|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 513/04 | (2006.01) |
| A61K 31/5377 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2201018 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08832577.4 |
| Date of filing the European patent application | 2008-09-19 | |
| (97) | Date of publication of the European application | 2010-06-30 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-16 |
| (46) | Date of publication of the claims translation | 2016-08-10 |
| (86) | Number | PCT/US2008/010884 |
| Date | 2008-09-19 |
| (87) | Number | WO 2009/038757 |
| Date | 2009-03-26 |
| (30) | Number | Date | Country code |
| 994635 P | 2007-09-19 | US |
| (72) |
BHAGWAT, Shripad, US
LAI, Wei, US
PARENT, Stephan, D., US
ROE, Melanie, J., US
SCHWARTZ, Alan, US
SMOLENSKAYA, Valeriya, N., US
|
| (73) |
Ambit Biosciences Corporation,
11080 Roselle Street San Diego, CA 92121,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kietos medžiagos, apimančios n-(5-tret-butilizoksazol-3-il)-N'-{4- 7-(2-morfolin-4-il-etoksi)imidazo[2,1-b][1,3]benzotiazol-2-il]fenil}karbamidą, jų kompozicijos ir panaudojimas |
| SOLID FORMS COMPRISING N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-N`-{4- 7-(2-MORPHOLIN-4-YL-ETHOXY)IMIDAZO 2,1-B 1,3 BENZOTHIAZOL-2-YL PHENYL}UREA, COMPOSITIONS THEREOF, AND USES THEREWITH |
| Payment date | Validity (years) | Amount | |
| 2024-08-20 | 17 | 347.00 EUR |
| 2025-09-19 |